Daiwa Securities Group Inc. - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 93 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$0860.0%0.00%
Q2 2022$0860.0%0.00%
Q1 2022$0860.0%0.00%
Q4 2021$0860.0%0.00%
Q3 2021$0
-100.0%
860.0%0.00%
Q2 2021$1,0000.0%860.0%0.00%
Q1 2021$1,0000.0%860.0%0.00%
Q4 2020$1,0000.0%86
-50.3%
0.00%
Q3 2019$1,0000.0%1730.0%0.00%
Q2 2019$1,0000.0%1730.0%0.00%
Q1 2019$1,0000.0%1730.0%0.00%
Q4 2018$1,000
-50.0%
1730.0%0.00%
Q3 2018$2,0000.0%1730.0%0.00%
Q2 2018$2,0000.0%1730.0%0.00%
Q1 2018$2,0001730.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,609,398$7,821,0001.64%
Telemetry Investments, L.L.C. 242,514$1,179,0001.59%
Omega Fund Management, LLC 2,606,809$12,669,0001.42%
Bruce & Co., Inc. 1,343,312$6,528,0001.39%
1492 Capital Management LLC 488,309$2,373,0001.20%
Abingworth LLP 1,041,131$5,060,0001.15%
Trellus Management Company, LLC 295,000$1,434,0001.04%
Worth Venture Partners, LLC 389,440$1,893,0000.85%
CM Management, LLC 200,000$972,0000.72%
GENERAL AMERICAN INVESTORS CO INC 1,112,658$5,408,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders